Does REGORAFENIB Cause Gait inability? 135 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 135 reports of Gait inability have been filed in association with REGORAFENIB (Stivarga). This represents 1.4% of all adverse event reports for REGORAFENIB.
135
Reports of Gait inability with REGORAFENIB
1.4%
of all REGORAFENIB reports
11
Deaths
47
Hospitalizations
How Dangerous Is Gait inability From REGORAFENIB?
Of the 135 reports, 11 (8.1%) resulted in death, 47 (34.8%) required hospitalization.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REGORAFENIB. However, 135 reports have been filed with the FAERS database.
What Other Side Effects Does REGORAFENIB Cause?
Off label use (1,906)
Fatigue (1,530)
Palmar-plantar erythrodysaesthesia syndrome (1,230)
Diarrhoea (1,221)
Decreased appetite (941)
Asthenia (825)
Death (813)
Dysphonia (702)
Nausea (688)
Pain in extremity (686)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which REGORAFENIB Alternatives Have Lower Gait inability Risk?
REGORAFENIB vs REGORAFENIB\REGORAFENIB
REGORAFENIB vs RELATLIMAB
REGORAFENIB vs RELPAX
REGORAFENIB vs RELUGOLIX
REGORAFENIB vs REMDESIVIR